Officer and Director at Nexalin Technology , Inc. (NASDAQ:NXL), recently acquired 1,000 shares of the company's common stock. The purchase, executed on February 4, 2025, was made at a price of $2.98 ...
In a recent transaction, Howard G. Welgus, a director at Arcutis Biotherapeutics Inc . (NASDAQ:ARQT), sold 10,000 shares of the company's common stock. The shares were sold at a weighted average price ...
Volcon, Inc. (Nasdaq:VLCN) (the “Company”), the first all-electric, off-road powersports company, today announced that it has commenced a public offering to offer and sell securities, including shares ...
Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” ...